FURADANTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Furadantin, and when can generic versions of Furadantin launch?
Furadantin is a drug marketed by Casper Pharma Llc and Procter And Gamble and is included in two NDAs.
The generic ingredient in FURADANTIN is nitrofurantoin. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Furadantin
A generic version of FURADANTIN was approved as nitrofurantoin by IMPAX LABS INC on January 28th, 1993.
Summary for FURADANTIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 2 |
Patent Applications: | 6,113 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FURADANTIN |
What excipients (inactive ingredients) are in FURADANTIN? | FURADANTIN excipients list |
DailyMed Link: | FURADANTIN at DailyMed |
Recent Clinical Trials for FURADANTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Early Phase 1 |
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi | Phase 3 |
Ministero della Salute, Italy | Phase 3 |
Pharmacology for FURADANTIN
Drug Class | Nitrofuran Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for FURADANTIN
US Patents and Regulatory Information for FURADANTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casper Pharma Llc | FURADANTIN | nitrofurantoin | SUSPENSION;ORAL | 009175-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Procter And Gamble | FURADANTIN | nitrofurantoin | TABLET;ORAL | 008693-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Casper Pharma Llc | FURADANTIN | nitrofurantoin | SUSPENSION;ORAL | 009175-002 | Jun 9, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Procter And Gamble | FURADANTIN | nitrofurantoin | TABLET;ORAL | 008693-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |